Walleye Trading LLC Akebia Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	SELL	$2.39 - $13.08 $26,051 - $142,572	-10,900 Reduced 37.2%	18,400 $46,000
Q2 2020 Aug 14, 2020	SELL	$6.67 - $13.58 $27,347 - $55,678	-4,100 Reduced 12.28%	29,300 $398,000
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $136,940 - $342,016	33,400 New	33,400 $253,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $8,520 - $12,960	-2,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $9,840 - $19,320	2,400 New	2,400 $12,000

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $353M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.